Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Sixian Liang(Cancer Hospital of Shantou University Medical College), Guo‐Jun Zhang(Xiamen University)
Oncotarget
December 11, 2014
Cited by 40


Related Papers